Novartis's older MS drug Gilenya wins Chinese approval
Novartis's Gilenya multiple sclerosis drug has won approval in China, the Swiss drugmaker said on Friday, as the company expands further into the world's most-populous country's growing healthcare sector.
from Reuters: Health News https://reut.rs/32Bmqgv
http://bit.ly/2zwRqiM